Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Lifelong premature ejaculation (LPE) is one of the most common ejaculatory dysfunctions in men. The serotonin (5-HT) synthesis rate-limiting enzyme ( TPH2) and receptor ( HTR1A) in the 5-HT regulatory system may play a key role in the pathogenesis of LPE. However, there are few studies on the effects of TPH2 and HTR1A polymorphisms on LPE risk. We speculated that TPH2 and HTR1A polymorphisms may affect the occurrence and development of LPE in the Chinese Han population.

          Methods

          In this study, 91 patients with LPE and 362 normal controls aged 18 to 64 years were enrolled in the male urology department of Hainan General Hospital in China from January 2016 to December 2018. The SNPs in HTR1A and TPH2, which are related to 5-HT regulation, were selected as indexes to genotype the collected blood samples of participants. Logistic regression was used to analyze the correlation between SNPs of HTR1A and TPH2 with LPE susceptibility, as well as the relationship with leptin, 5-HT and folic acid levels.

          Results

          The results revealed that HTR1A-rs6295 increased LPE risk in recessive model. Rs11178996 in TPH2 significantly reduced susceptibility to LPE in allelic (odds ratio (OR) = 0.68, 95% confidence interval (95% CI) = 0.49–0.96, p = 0.027), codominant (OR = 0.58, 95% CI = 0.35–0.98, p = 0.040), dominant (OR = 0.58, 95% CI = 0.36–0.92, p = 0.020), and additive (OR = 0.71, 95% CI = 0.52–0.98, p = 0.039) models. G rs11179041T rs10879352 could reduce the risk of LPE (OR = 0.44, 95% CI = 0.22–0.90, p = 0.024) by haplotype analysis.

          Conclusion

          HTR1A-rs6295 and TPH2-rs11178996 are associated with LPE risk in the Chinese Han population based on the finding of this study.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: not found
          • Article: not found

          European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.

            The International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation developed the first evidence-based definition for lifelong premature ejaculation (PE) in 2007 and concluded that there were insufficient published objective data at that time to develop a definition for acquired PE.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE).

              In 2009, the International Society for Sexual Medicine (ISSM) convened a select panel of experts to develop an evidence-based set of guidelines for patients suffering from lifelong premature ejaculation (PE). That document reviewed definitions, etiology, impact on the patient and partner, assessment, and pharmacological, psychological, and combined treatments. It concluded by recognizing the continually evolving nature of clinical research and recommended a subsequent guideline review and revision every fourth year. Consistent with that recommendation, the ISSM organized a second multidisciplinary panel of experts in April 2013, which met for 2 days in Bangalore, India. This manuscript updates the previous guidelines and reports on the recommendations of the panel of experts. The aim of this study was to develop clearly worded, practical, evidenced-based recommendations for the diagnosis and treatment of PE for family practice clinicians as well as sexual medicine experts. A comprehensive literature review was performed. This article contains the report of the second ISSM PE Guidelines Committee. It offers a new unified definition of PE and updates the previous treatment recommendations. Brief assessment procedures are delineated, and validated diagnostic and treatment questionnaires are reviewed. Finally, the best practices treatment recommendations are presented to guide clinicians, both familiar and unfamiliar with PE, in facilitating treatment of their patients. Development of guidelines is an evolutionary process that continually reviews data and incorporates the best new research. We expect that ongoing research will lead to a more complete understanding of the pathophysiology as well as new efficacious and safe treatments for this sexual dysfunction. We again recommend that these guidelines be reevaluated and updated by the ISSM in 4 years. © 2014 International Society for Sexual Medicine.
                Bookmark

                Author and article information

                Contributors
                wangweifu622@163.com
                Journal
                BMC Urol
                BMC Urol
                BMC Urology
                BioMed Central (London )
                1471-2490
                9 May 2023
                9 May 2023
                2023
                : 23
                : 86
                Affiliations
                [1 ]GRID grid.459560.b, ISNI 0000 0004 1764 5606, Department of Urology, , Hainan General Hospital, Affiliated Hainan Hospital of Hainan Medical University, ; No.19, Xiuhua Road, Xiuying District, Haikou, Hainan Province 570311 China
                [2 ]GRID grid.443397.e, ISNI 0000 0004 0368 7493, Department of Lung Transplatation, , The Second Affiliated Hospital of Hainan Medical University, ; Haikou, Hainan 571199 China
                [3 ]GRID grid.449838.a, ISNI 0000 0004 1757 4123, Department of Urology, , Affiliated Hospital of Xiangnan University, ; Chenzhou, Hunan 423000 China
                [4 ]GRID grid.502812.c, Ministry of Science and Education, , Hainan Women and Children’s Medical Center, ; Haikou, Hainan 571100 China
                [5 ]GRID grid.443397.e, ISNI 0000 0004 0368 7493, Library, , Hainan Medical University, ; Haikou, Hainan 571199 China
                [6 ]GRID grid.443397.e, ISNI 0000 0004 0368 7493, Department of Kidney Transplatation, , The Second Affiliated Hospital of Hainan Medical University, ; Haikou, Hainan Province 571199 China
                Article
                1222
                10.1186/s12894-023-01222-9
                10170821
                37161455
                5944531e-12e9-475a-8cd8-1c70b339e939
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 30 June 2022
                : 21 March 2023
                Funding
                Funded by: National Natural Science Foundation of China: Project of Regional Science Foundation
                Award ID: No. 81560250
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2023

                Urology
                lifelong premature ejaculation (lpe),case-control study,single nucleotide polymorphism (snp),tph2,htr1a,5-hydroxytryptamine (5-ht)

                Comments

                Comment on this article